PubRank

Rohana Yusof

Author PubWeight™ 18.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Induction of MHC Class I HLA-A2 promoter by dengue virus occurs at the NFκB binding domains of the Class I Regulatory Complex. Virus Res 2011 1.51
2 Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett 2006 1.35
3 Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites. J Chem Inf Model 2008 1.00
4 Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors. Electrophoresis 2004 0.99
5 Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest 2006 0.97
6 Antiviral actions of flavanoid-derived compounds on dengue virus type-2. Int J Biol Sci 2010 0.91
7 Differential proteome analysis of chikungunya virus infection on host cells. PLoS One 2013 0.90
8 The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever. Trans R Soc Trop Med Hyg 2009 0.87
9 Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect Dis 2012 0.87
10 Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells. J Biomed Biotechnol 2012 0.86
11 Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells. J Gen Virol 2011 0.85
12 Boesenbergia rotunda: From Ethnomedicine to Drug Discovery. Evid Based Complement Alternat Med 2012 0.84
13 Inhibitory potential of Quercus lusitanica extract on dengue virus type 2 replication. Southeast Asian J Trop Med Public Health 2006 0.83
14 Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide. OMICS 2013 0.80
15 Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus. BMC Microbiol 2014 0.78
16 All serotypes of dengue virus induce HLA-A2 major histocompatibility complex class I promoter activity in human liver cells. Trans R Soc Trop Med Hyg 2010 0.78
17 Inhibitory effect of doxycycline against dengue virus replication in vitro. Arch Virol 2013 0.76
18 Rational discovery of dengue type 2 non-competitive inhibitors. Chem Biol Drug Des 2013 0.76
19 Current approaches in antiviral drug discovery against the Flaviviridae family. Curr Pharm Des 2014 0.76
20 Fragment-based molecular design of new competitive dengue Den2 Ns2b/Ns3 inhibitors from the components of fingerroot (Boesenbergia rotunda). In Silico Biol 2012 0.76
21 AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity. Protein Sci 2015 0.75
22 Rational drug discovery of HCV helicase inhibitor: Improved docking accuracy with multiple seedings of Autodock Vina and in situ minimization. Curr Comput Aided Drug Des 2016 0.75
23 Reversible thermo-pneumatic valves on centrifugal microfluidic platforms. Lab Chip 2015 0.75
24 Neurovirulence of four encephalitogenic dengue 3 virus strains isolated in Malaysia (1992-1994) is not attributed to their envelope protein. Trans R Soc Trop Med Hyg 2004 0.75
25 Analysis of secondary structure predictions of dengue virus type 2 NS2B/NS3 against crystal structure to evaluate the predictive power of the in silico methods. In Silico Biol 2007 0.75
26 Differential expression of aldolase, alpha tubulin and thioredoxin peroxidase in peripheral blood mononuclear cells from dengue fever and dengue hemorrhagic fever patients. Southeast Asian J Trop Med Public Health 2009 0.75
27 Dengue envelope domain III-peptide binding analysis via tryptophan fluorescence quenching assay. Chem Pharm Bull (Tokyo) 2014 0.75